E. Link
University of Düsseldorf
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by E. Link.
The Journal of Allergy and Clinical Immunology | 2008
Andrea von Berg; Birgit Filipiak-Pittroff; Ursula Krämer; E. Link; Christina Bollrath; Inken Brockow; Sibylle Koletzko; Armin Grübl; Joachim Heinrich; H.-Erich Wichmann; Carl-P. Bauer; Dietrich Reinhardt; Dietrich Berdel
BACKGROUND The long-term effect of nutritional intervention with hydrolyzed infant formulas on allergy development has not been sufficiently evaluated. OBJECTIVE We performed a follow-up of the German Infant Nutritional Intervention study until 6 years of life to investigate the long-term allergy-preventive effect of 3 hydrolyzed infant formulas compared with cows milk formula (CMF) in a randomized, double-blind trial. METHODS Between 1995 and 1998, 2252 newborns with atopic heredity were randomly assigned at birth to receive one of 4 blinded formulas: partially or extensively hydrolyzed whey formula, extensively hydrolyzed casein formula, or CMF as milk substitute for the first 4 months when breast-feeding was insufficient. The cohort was followed from birth until 6 years of age with yearly questionnaires. Outcomes were physician-diagnosed allergic diseases (atopic dermatitis, food allergy, allergic urticaria, asthma, and hay fever/allergic rhinitis). Log-binomial regression modeled with generalized estimation equations was used for the statistical analysis. RESULTS In the intent-to-treat analysis the relative risk of a physicians diagnosis of allergic manifestation (AM) compared with CMF was 0.82 (95% CI, 0.70-0.96) for partially hydrolyzed whey formula, 0.90 (95% CI, 0.78-1.04) for extensively hydrolyzed whey formula, and 0.80 (95% CI, 0.69-0.93) for extensively hydrolyzed casein formula. The corresponding figures for atopic eczema were 0.79 (95% CI, 0.64-0.97), 0.92 (95% CI, 0.76-1.11), and 0.71 (95% CI, 0.58-0.88), respectively. In the per-protocol analysis all effects were stronger and significant. No significant effect on other AMs was found. CONCLUSION The data confirm a long-term allergy-preventive effect of hydrolyzed infant formulas on AM and atopic eczema until 6 years of age.
British Journal of Dermatology | 2004
Ursula Krämer; C.H. Lemmen; Heidrun Behrendt; E. Link; T. Schäfer; Johannes-Georg Gostomzyk; G. Scherer; J. Ring
Background The negative impact of environmental tobacco smoke (ETS) on airway diseases in children is well known. Whether there is an effect on atopic eczema is not clear.
Clinical & Experimental Allergy | 2010
Andrea von Berg; Ursula Krämer; E. Link; C. Bollrath; Joachim Heinrich; I. Brockow; S. Koletzko; Armin Grübl; B. Filipiak‐Pittroff; H-Erich Wichmann; Carl-Peter Bauer; Dietrich Reinhardt; Dietrich Berdel
Background Nutritional intervention with hydrolysed infant formulas has been shown efficacious in preventing eczema in children predisposed to allergy. However, this preventive effect has never been related to the natural course of eczema in children with or without a family history of allergy. The aim of this study therefore was to compare the course of eczema in predisposed children after nutritional intervention to the natural course of eczema.
The Journal of Allergy and Clinical Immunology | 2013
Andrea von Berg; Birgit Filipiak-Pittroff; Ursula Krämer; Barbara Hoffmann; E. Link; C. Beckmann; Ute Hoffmann; Dietrich Reinhardt; Armin Grübl; Joachim Heinrich; H.-Erich Wichmann; Carl-P. Bauer; Sibylle Koletzko; Dietrich Berdel
BACKGROUND The long-term effect of nutritional intervention with hydrolysate infant formulas on allergic manifestations in high-risk children is uncertain. OBJECTIVE We sought to investigate the effect of hydrolysate infant formulas on allergic phenotypes in children with family history of allergies at school age. METHODS We analyzed data from participants of the prospective German Infant Nutritional Intervention study after 10 years of follow-up. At birth, children were randomly assigned to receive, for the first 4 months, one of 4 blinded formulas as breast milk substitute, if necessary: partially hydrolyzed whey formula (pHF-W), extensively hydrolyzed whey formula (eHF-W), extensively hydrolyzed casein formula (eHF-C), or standard cows milk formula. Outcomes were parent-reported, physician-diagnosed allergic diseases. Log-binomial regression models were used for statistical analysis. RESULTS The relative risk for the cumulative incidence of any allergic disease in the intention-to-treat analysis (n = 2252) was 0.87 (95% CI, 0.77-0.99) for pHF-W, 0.94 (95% CI, 0.83-1.07) for eHF-W, and 0.83 (95% CI, 0.72-0.95) for eHF-C compared with standard cows milk formula. The corresponding figures for atopic eczema/dermatits (AD) were 0.82 (95% CI, 0.68-1.00), 0.91 (95% CI, 0.76-1.10), and 0.72 (95% CI, 0.58-0.88), respectively. In the per-protocol analysis (n = 988) effects were stronger. The period prevalence of AD at 7 to 10 years was significantly reduced with eHF-C in this analysis, but there was no preventive effect on asthma or allergic rhinitis. CONCLUSION The significant preventive effect on the cumulative incidence of allergic diseases, particularly AD, with pHF-W and eHF-C persisted until 10 years without rebound, whereas eHF-W showed no significant risk reduction. There is insufficient evidence of ongoing preventive activity at 7 to 10 years of age.
Allergy | 2011
Christina Tischer; Cynthia Hohmann; Elisabeth Thiering; Olf Herbarth; A. Müller; John Henderson; Raquel Granell; Maria Pia Fantini; L. Luciano; Anna Bergström; Inger Kull; E. Link; A. von Berg; Claudia E. Kuehni; Marie-Pierre F. Strippoli; Ulrike Gehring; Alet H. Wijga; Esben Eller; Carsten Bindslev-Jensen; Thomas Keil; Joachim Heinrich
To cite this article: Tischer CG, Hohmann C, Thiering E, Herbarth O, Müller A, Henderson J, Granell R, Fantini MP, Luciano L, Bergström A, Kull I, Link E, von Berg A, Kuehni CE, Strippoli M‐PF, Gehring U, Wijga A, Eller E, Bindslev‐Jensen C, Keil T, Heinrich J & as part of the ENRIECO consortium. Meta‐analysis of mould and dampness exposure on asthma and allergy in eight European birth cohorts: an ENRIECO initiative. Allergy 2011; 66: 1570–1579.
Acta Paediatrica | 2007
Anne Zutavern; Peter Rzehak; Inken Brockow; Beate Schaaf; Christina Bollrath; Andrea von Berg; E. Link; Ursula Kraemer; Michael Borte; Olf Herbarth; H-Erich Wichmann; Joachim Heinrich
Aim: To describe day care attendance in Germany today (in former East and former West Germany). To investigate longitudinally whether children attending day care centres have an increased risk of acquiring common cold, bronchitis, pneumonia, otitis media or diarrhea.
Allergy | 2016
A. von Berg; Birgit Filipiak-Pittroff; Holger Schulz; Ute Hoffmann; E. Link; M. Sußmann; M. Schnappinger; Irene Brüske; Marie Standl; Ursula Krämer; Barbara Hoffmann; Joachim Heinrich; Carl-Peter Bauer; S. Koletzko; Dietrich Berdel
Data on the long‐term impact of hydrolyzed formulas on allergies are scarce.
The Journal of Allergy and Clinical Immunology | 2010
C. Cramer; E. Link; Maike Horster; Sibylle Koletzko; Carl-P. Bauer; Dietrich Berdel; Andrea von Berg; Irina Lehmann; Olf Herbarth; Michael Borte; Beate Schaaf; Heidrun Behrendt; Chih-Mei Chen; Stefanie Sausenthaler; Thomas Illig; H.-Erich Wichmann; Joachim Heinrich; Ursula Krämer
BACKGROUND Several studies showed a protective effect of elder siblings on eczema development, which is in line with the hygiene hypothesis. However, findings are not consistent, and there might exist different causal pathways for the development of eczema. Especially barrier disturbances as found in children with mutations in the filaggrin gene (FLG) seem to play an important role. OBJECTIVES To investigate the interaction between FLG mutations and the presence of elder siblings on the development of eczema in 2 independent birth cohorts. METHODS We used data from 2 German birth cohorts (LISAplus, GINIplus) up to the age of 6 years. Genotyping for FLG mutations (R501X, 2282del4) was performed in 1039 (LISAplus) and 1828 (GINIplus) children. Data on eczema (diagnosis and symptoms) and elder siblings were obtained by parental questionnaires. The association among eczema, FLG mutations, and elder siblings was analyzed longitudinally by using generalized estimating equations. RESULTS We found no protective effect of elder siblings on eczema development. On the contrary, children with FLG mutations had a significantly higher risk for eczema if they had elder siblings. Attending day care centers lessened this effect. After excluding 303 children who attended early day care, the odds ratio for interaction between FLG mutations and elder siblings was 3.27 (95% CI, 1.14-9.36) in LISAplus and 2.41 (95% CI, 1.06-5.48) in GINIplus. CONCLUSION Our findings did not confirm a protective sibling effect. The prevalence of eczema in children with filaggrin deficiency was higher if elder siblings were present. Our results give evidence for complex skin-driven pathogenic mechanisms that might be different depending on childrens genetic backgrounds.
British Journal of Dermatology | 2006
Ursula Krämer; C.H. Lemmen; E. Bartusel; E. Link; J. Ring; Heidrun Behrendt
Background Mite allergen exposure is an important risk factor for specific IgE production and is associated with asthma, hay fever and eczema. Whether these associations are independent of mite species has not been investigated so far.
Journal of Exposure Science and Environmental Epidemiology | 2004
Gerhard Scherer; Ursula Krämer; Irmtrud Meger-Kossien; Kirsten Riedel; Wolf-Dieter Heller; E. Link; Johannes-Georg Gostomzyk; Johannes Ring; Heidrun Behrendt
Maternal smoking has been repeatedly found to be the most important determinant of childrens exposure to environmental tobacco smoke (ETS). Here, we further investigated predictors for the urinary cotinine/creatinine ratio (CCR, ng/mg) in 1220 preschool children for the year 1996. Children from smoking homes (35.1%) had significantly higher CCR than children from nonsmoking homes (mean: 55.5 vs. 14.9 ng/mg). The level of education of the parents was a strong predictor for CCRs even after adjusting for number of cigarettes smoked, maternal smoking and dwelling space. Additionally, dwelling space was inversely related to childrens urinary cotinine level. The CCR- levels in children investigated in 1996 and 1998 were significantly correlated (Pearsons r=0.67). The parents of 806 children agreed for a visit to their homes. In 79 of the 536 (14.7%) of the self-reported, nonsmoking households, smoking was admitted during the visit. The mean urinary CCR of these children was 25.2 ng/mg. We conclude that in addition to parental smoking behaviour, other variables such as dwelling space and social and educational status predict the childrens exposure to ETS. Our data also revealed that a considerable percentage of parents denied the ETS exposure of their children at home.